John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HONE
1626
DELISTED
HarborOne Bancorp
HONE
| $2.16M | ﹤0.01% |
207,941
+81,359
| +64% | +$930K |
|
|
ADAM
1627
Adamas Trust
ADAM
$884M
| $2.15M | ﹤0.01% |
331,281
+79,875
| +32% | +$509K |
|
1628
Titan International
TWI
$464M
| $2.15M | ﹤0.01% |
256,123
+131,506
| +106% | +$1.09M |
|
1629
Designer Brands
DBI
$280M
| $2.15M | ﹤0.01% |
587,965
-119,881
| -17% | -$564K |
|
|
TEN
1630
Tsakos Energy Navigation Ltd
TEN
$1.27B
| $2.14M | ﹤0.01% |
125,661
-143,907
| -53% | -$2.51M |
|
1631
TTEC Holdings
TTEC
$69M
| $2.14M | ﹤0.01% |
651,048
-64,337
| -9% | -$237K |
|
|
BBOT
1632
BridgeBio Oncology
BBOT
$751M
| $2.14M | ﹤0.01% |
189,285
| – | – |
|
1633
Deckers Outdoor
DECK
$12.1B
| $2.14M | ﹤0.01% |
19,100
-785
| -4% | -$127K |
|
1634
Manitowoc
MTW
$702M
| $2.13M | ﹤0.01% |
248,111
+53,325
| +27% | +$520K |
|
1635
RLX Technology
RLX
$2.19B
| $2.13M | ﹤0.01% |
1,132,917
-26,000
| -2% | -$57.6K |
|
|
GES
1636
PUT
DELISTED
Guess Inc
GES
| $2.13M | ﹤0.01% |
192,100
| – | – |
|
1637
Travelers Companies
TRV
$77.1B
| $2.12M | ﹤0.01% |
8,031
+27
| +0.3% | +$6.73K |
|
1638
Navios Maritime Partners
NMM
$2.58B
| $2.11M | ﹤0.01% |
53,841
-84,939
| -61% | -$3.58M |
|
1639
Teva Pharmaceuticals
TEVA
$44.4B
| $2.1M | ﹤0.01% |
136,797
-549,658
| -80% | -$9.82M |
|
|
FINV
1640
FinVolution Group
FINV
$1.03B
| $2.09M | ﹤0.01% |
217,526
-303,573
| -58% | -$2.49M |
|
|
REFI
1641
Chicago Atlantic Real Estate Finance
REFI
$277M
| $2.09M | ﹤0.01% |
142,199
+13,461
| +10% | +$210K |
|
1642
Aon
AON
$75.3B
| $2.09M | ﹤0.01% |
5,234
-48,226
| -90% | -$18.5M |
|
1643
United Parks & Resorts
PRKS
$1.98B
| $2.09M | ﹤0.01% |
45,887
+30,316
| +195% | +$1.57M |
|
1644
ProShares Russell 2000 Dividend Growers ETF
SMDV
$747M
| $2.09M | ﹤0.01% |
31,800
+13,300
| +72% | +$901K |
|
1645
Afya
AFYA
$1.27B
| $2.08M | ﹤0.01% |
116,131
+44,047
| +61% | +$735K |
|
1646
Mid Penn Bancorp
MPB
$937M
| $2.08M | ﹤0.01% |
80,299
+21,498
| +37% | +$605K |
|
|
EQC
1647
DELISTED
Equity Commonwealth
EQC
| $2.08M | ﹤0.01% |
1,291,483
-76,804
| -6% | -$129K |
|
1648
AGNC Investment
AGNC
$12.9B
| $2.07M | ﹤0.01% |
216,157
-71,936
| -25% | -$718K |
|
1649
Peapack-Gladstone Financial
PGC
$800M
| $2.06M | ﹤0.01% |
72,694
+16,726
| +30% | +$525K |
|
1650
Vanguard US Value Factor ETF
VFVA
$942M
| $2.06M | ﹤0.01% |
18,100
+5,200
| +40% | +$620K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.